Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells

Tisheeka R. Graham, Rami Yacoub, Latonia Taliaferro-Smith, Adeboye O. Osunkoya, Valerie A. Odero-Marah, Tongrui Liu, K. Sean Kimbro, Dipali Sharma, Ruth M. O'Regan

Research output: Contribution to journalArticle

Abstract

Zinc-finger enhancer binding protein (ZEB1) is a transcription factor involved in the progression of cancer primarily through promoting epithelial to mesenchymal transition (EMT). ZEB1 represses the expression of E-cadherin by binding to E-box sequences in the promoter, thus decreasing epithelial differentiation. We show that ZEB1 and androgen receptor (AR) cross-talk in triple negative breast cancer cell lines. Chromatin immunoprecipitation analysis demonstrates that ZEB1 binds directly to the E-box located in the AR promoter. ZEB1 suppression by stably transfecting shRNA in a triple negative breast cancer cell line resulted in a decrease of AR mRNA, protein, and AR downstream targets. ZEB1 knockdown in triple negative breast cancer cells sensitized the cells to bicalutamide by reducing migration compared to the control cells. Conversely, blockade of AR signaling with bicalutamide resulted in a suppression of ZEB1 protein expression in two triple negative breast cancer cell lines. Furthermore, using a breast cancer tissue microarray, a majority of triple negative breast cancers exhibit positive staining for both ZEB1 and AR. Taken together, these results indicate that ZEB1 and AR regulate each other to promote cell migration in triple negative breast cancer cells.

Original languageEnglish (US)
Pages (from-to)139-147
Number of pages9
JournalBreast Cancer Research and Treatment
Volume123
Issue number1
DOIs
StatePublished - Aug 2010
Externally publishedYes

Fingerprint

Triple Negative Breast Neoplasms
Androgen Receptors
Cell Line
Receptor Cross-Talk
E-Box Elements
Epithelial-Mesenchymal Transition
Chromatin Immunoprecipitation
Zinc Fingers
Cadherins
Small Interfering RNA
Cell Movement
Carrier Proteins
Proteins
Transcription Factors
Staining and Labeling
Breast Neoplasms
Messenger RNA

Keywords

  • AR
  • Breast cancer
  • Triple negative
  • ZEB1

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Medicine(all)

Cite this

Graham, T. R., Yacoub, R., Taliaferro-Smith, L., Osunkoya, A. O., Odero-Marah, V. A., Liu, T., ... O'Regan, R. M. (2010). Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells. Breast Cancer Research and Treatment, 123(1), 139-147. https://doi.org/10.1007/s10549-009-0623-7

Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells. / Graham, Tisheeka R.; Yacoub, Rami; Taliaferro-Smith, Latonia; Osunkoya, Adeboye O.; Odero-Marah, Valerie A.; Liu, Tongrui; Kimbro, K. Sean; Sharma, Dipali; O'Regan, Ruth M.

In: Breast Cancer Research and Treatment, Vol. 123, No. 1, 08.2010, p. 139-147.

Research output: Contribution to journalArticle

Graham, TR, Yacoub, R, Taliaferro-Smith, L, Osunkoya, AO, Odero-Marah, VA, Liu, T, Kimbro, KS, Sharma, D & O'Regan, RM 2010, 'Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells', Breast Cancer Research and Treatment, vol. 123, no. 1, pp. 139-147. https://doi.org/10.1007/s10549-009-0623-7
Graham TR, Yacoub R, Taliaferro-Smith L, Osunkoya AO, Odero-Marah VA, Liu T et al. Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells. Breast Cancer Research and Treatment. 2010 Aug;123(1):139-147. https://doi.org/10.1007/s10549-009-0623-7
Graham, Tisheeka R. ; Yacoub, Rami ; Taliaferro-Smith, Latonia ; Osunkoya, Adeboye O. ; Odero-Marah, Valerie A. ; Liu, Tongrui ; Kimbro, K. Sean ; Sharma, Dipali ; O'Regan, Ruth M. / Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells. In: Breast Cancer Research and Treatment. 2010 ; Vol. 123, No. 1. pp. 139-147.
@article{4653b9ac05e144cdbdb8c113c5f7e1ee,
title = "Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells",
abstract = "Zinc-finger enhancer binding protein (ZEB1) is a transcription factor involved in the progression of cancer primarily through promoting epithelial to mesenchymal transition (EMT). ZEB1 represses the expression of E-cadherin by binding to E-box sequences in the promoter, thus decreasing epithelial differentiation. We show that ZEB1 and androgen receptor (AR) cross-talk in triple negative breast cancer cell lines. Chromatin immunoprecipitation analysis demonstrates that ZEB1 binds directly to the E-box located in the AR promoter. ZEB1 suppression by stably transfecting shRNA in a triple negative breast cancer cell line resulted in a decrease of AR mRNA, protein, and AR downstream targets. ZEB1 knockdown in triple negative breast cancer cells sensitized the cells to bicalutamide by reducing migration compared to the control cells. Conversely, blockade of AR signaling with bicalutamide resulted in a suppression of ZEB1 protein expression in two triple negative breast cancer cell lines. Furthermore, using a breast cancer tissue microarray, a majority of triple negative breast cancers exhibit positive staining for both ZEB1 and AR. Taken together, these results indicate that ZEB1 and AR regulate each other to promote cell migration in triple negative breast cancer cells.",
keywords = "AR, Breast cancer, Triple negative, ZEB1",
author = "Graham, {Tisheeka R.} and Rami Yacoub and Latonia Taliaferro-Smith and Osunkoya, {Adeboye O.} and Odero-Marah, {Valerie A.} and Tongrui Liu and Kimbro, {K. Sean} and Dipali Sharma and O'Regan, {Ruth M.}",
year = "2010",
month = "8",
doi = "10.1007/s10549-009-0623-7",
language = "English (US)",
volume = "123",
pages = "139--147",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells

AU - Graham, Tisheeka R.

AU - Yacoub, Rami

AU - Taliaferro-Smith, Latonia

AU - Osunkoya, Adeboye O.

AU - Odero-Marah, Valerie A.

AU - Liu, Tongrui

AU - Kimbro, K. Sean

AU - Sharma, Dipali

AU - O'Regan, Ruth M.

PY - 2010/8

Y1 - 2010/8

N2 - Zinc-finger enhancer binding protein (ZEB1) is a transcription factor involved in the progression of cancer primarily through promoting epithelial to mesenchymal transition (EMT). ZEB1 represses the expression of E-cadherin by binding to E-box sequences in the promoter, thus decreasing epithelial differentiation. We show that ZEB1 and androgen receptor (AR) cross-talk in triple negative breast cancer cell lines. Chromatin immunoprecipitation analysis demonstrates that ZEB1 binds directly to the E-box located in the AR promoter. ZEB1 suppression by stably transfecting shRNA in a triple negative breast cancer cell line resulted in a decrease of AR mRNA, protein, and AR downstream targets. ZEB1 knockdown in triple negative breast cancer cells sensitized the cells to bicalutamide by reducing migration compared to the control cells. Conversely, blockade of AR signaling with bicalutamide resulted in a suppression of ZEB1 protein expression in two triple negative breast cancer cell lines. Furthermore, using a breast cancer tissue microarray, a majority of triple negative breast cancers exhibit positive staining for both ZEB1 and AR. Taken together, these results indicate that ZEB1 and AR regulate each other to promote cell migration in triple negative breast cancer cells.

AB - Zinc-finger enhancer binding protein (ZEB1) is a transcription factor involved in the progression of cancer primarily through promoting epithelial to mesenchymal transition (EMT). ZEB1 represses the expression of E-cadherin by binding to E-box sequences in the promoter, thus decreasing epithelial differentiation. We show that ZEB1 and androgen receptor (AR) cross-talk in triple negative breast cancer cell lines. Chromatin immunoprecipitation analysis demonstrates that ZEB1 binds directly to the E-box located in the AR promoter. ZEB1 suppression by stably transfecting shRNA in a triple negative breast cancer cell line resulted in a decrease of AR mRNA, protein, and AR downstream targets. ZEB1 knockdown in triple negative breast cancer cells sensitized the cells to bicalutamide by reducing migration compared to the control cells. Conversely, blockade of AR signaling with bicalutamide resulted in a suppression of ZEB1 protein expression in two triple negative breast cancer cell lines. Furthermore, using a breast cancer tissue microarray, a majority of triple negative breast cancers exhibit positive staining for both ZEB1 and AR. Taken together, these results indicate that ZEB1 and AR regulate each other to promote cell migration in triple negative breast cancer cells.

KW - AR

KW - Breast cancer

KW - Triple negative

KW - ZEB1

UR - http://www.scopus.com/inward/record.url?scp=77955769681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955769681&partnerID=8YFLogxK

U2 - 10.1007/s10549-009-0623-7

DO - 10.1007/s10549-009-0623-7

M3 - Article

C2 - 19921427

AN - SCOPUS:77955769681

VL - 123

SP - 139

EP - 147

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -